Related Experiment Video
Updated: Jul 21, 2025

Optimization of the Cuff Technique for Murine Heart Transplantation
Published on: June 26, 2020
New system, old problem: Increased wait time for high-priority transplant candidates
Erin Harris1, Lorenzo Sewanan1, Veli K Topkara1
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, New York.
Insights
The 2018 heart transplant policy did not change wait times for the sickest patients (Status 1). However, wait times for Status 2 heart transplant candidates significantly increased post-policy.
Area of Science:
- Cardiology
- Transplant Surgery
- Public Health Policy
Background:
- The 2018 heart allocation policy aimed to optimize organ distribution and reduce mortality among critically ill patients awaiting transplantation.
- Previous allocation systems faced challenges in effectively stratifying risk and prioritizing the sickest candidates.
Purpose of the Study:
- To evaluate the impact of the 2018 heart allocation policy on wait times for adult, single-organ heart transplant recipients.
- To assess changes in waitlist duration stratified by patient priority status, blood type, and geographic region.
Main Methods:
- Analysis of adult single-organ heart transplant recipients from the United Network for Organ Sharing (UNOS) registry.
- Data collection spanned from October 18, 2018, to July 8, 2022, divided into four post-policy implementation periods.
- Comparison of median and mean wait times based on priority status (Status 1 vs. Status 2), blood type, and UNOS region.
Main Results:
- No significant change in median wait times was observed for Status 1 (highest priority) patients.
- A statistically significant increase of 4.2 days in mean wait time was found for Status 2 patients with each subsequent period post-policy.
- Wait times were longest for blood type O and shortest for blood types AB and A, with regional variations persisting and increasing over time.
Conclusions:
- The 2018 heart allocation policy did not improve wait times for the highest acuity patients (Status 1).
- The policy was associated with a progressive increase in wait times for Status 2 heart transplant candidates.
- Blood type O and regional factors continue to influence heart transplant wait times, necessitating further policy refinement.
Abstract:
The 2018 heart allocation policy sought to improve risk stratification and reduce waitlist mortality for the sickest patients. This study sought to evaluate changes in wait times for the highest priority patients since policy implementation. All adult single-organ transplant recipients were identified in the United Network for Organ Sharing registry from October 18, 2018, to July 8, 2022, and separated into 4 periods. Outcomes were compared by blood type and UNOS region. Over the study period, 897 of 9,143 patients were listed as status 1 with no significant change in median wait time by blood type or region. More patients were listed as status 2 (4,523/9,143), and each subsequent period postpolicy change was associated with a 4.2-day increase in mean status 2 waitlist time (95% confidence interval 3.0-5.5, p < 0.0001). Wait times were longest for candidates with blood type O and shortest for AB & A. Regional variations continued, however, wait time increased in every region over time.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

